RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVAX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Novavax stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session.
(Updated on Jul 03, 2024)

Hold candidate since Jul 03, 2024 PDF

The Novavax stock price fell by -3.24% on the last day (Wednesday, 3rd Jul 2024) from $12.97 to $12.55. During the last trading day the stock fluctuated 6.17% from a day low at $12.44 to a day high of $13.21. The price has fallen in 6 of the last 10 days and is down by -8.96% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -94 thousand shares and in total, 4 million shares were bought and sold for approximately $45.73 million.

Given the current short-term trend, the stock is expected to rise 139.33% during the next 3 months and, with a 90% probability hold a price between $30.04 and $61.09 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVAX Signals & Forecast

There are few to no technical positive signals at the moment. The Novavax stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.98 and $14.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 05, 2024, and so far it has fallen -40.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Novavax stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.768 between high and low, or 6.17%. For the last week, the stock has had daily average volatility of 6.22%.

Novavax is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: $11.70 (-6.74%) (This stock has very high daily movements and this gives very high risk. Low RSI14 is 13 which reduces the risk some. There is a sell signal from a pivot top found 53 days ago.)

Trading Expectations (NVAX) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Novavax Inc to open at $12.73, and during the day (based on 14 day Average True Range), to move between $11.28 and $13.82, which gives a possible trading interval of +/-$1.27 (+/-10.11%) up or down from last closing price. If Novavax Inc takes out the full calculated possible swing range there will be an estimated 20.22% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $13.11, some $0.560 (4.46%) from the current price of $12.55, our system finds the risk reward not very attractive.

Is Novavax Inc stock A Buy?

Novavax holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.465 Hold/Accumulate Upgraded

Predicted Opening Price for Novavax Inc of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$12.73 ( 1.47%) $12.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
R3 13.50 7.58%
R2 13.21 5.25%
R1 13.03 3.80%
Price 12.55
S1 12.44 -0.87%
S2 12.26 -2.31%
S3 11.97 -4.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.40 14.74%
R2 13.48 7.41%
R1 13.11 4.46%
Price 12.55
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Novavax Stock and on which exchange is it traded?
The symbol for Novavax is NVAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Novavax Stock?
Novavax holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Novavax Stock?
Novavax Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novavax Stock.

What's the current price of Novavax Stock?
As of the end of day on the Jul 03, 2024, the price of an Novavax (NVAX) share was $12.55.

What is the 52-week high and low for Novavax Stock?
The 52-week high for Novavax Stock is $23.86 and the 52-week low is $3.53.

What is the market capitalization of Novavax Stock?
As of the Jul 03, 2024, the market capitalization of Novavax is 1.787B.

When is the next earnings date for Novavax?
The upcoming earnings date for Novavax is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT